Overview

Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral Sclerosis

Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and effectiveness of intravenous infusion of plasma from healthy young people for the treatment of amyotrophic lateral sclerosis.
Phase:
Early Phase 1
Details
Lead Sponsor:
Peking University Third Hospital
Treatments:
Riluzole